Author:
Krishna Yerramneni Vamsi,Reddy Kanala Ramanadha,S. Rangan Vasundhara,Yerragunta Thirumal
Reference37 articles.
1. Central Brain Tumor Registry of the United States. Central Brain Tumor Registry of the United States Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2010
2. Despite advances in diagnostic technology, surgical techniques and adjuvant treatments, the prognosis remains poor and the median overall survival (OS) of patients has increased only 3.3 months (from 11.3 months to 14.6 months) over the past 25 years
3. Robin AM, Lee I, Kalkanis SN. Reoperation for recurrent glioblastoma multiforme. Neurosurgery Clinics. 2017;28(3):407-428
4. Sanai N, Polley M-Y, McDermott MW, et al. An extent of resection threshold for newly diagnosed glioblastomas. Journal of Neurosurgery. 2011;115(1):3
5. Macdonald D, Cascino T, Schold SJ, et al. Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology. 1990;8:1277-1280